November 19th 2020
Robert M. Dean, MD, discusses remaining challenges in diffuse large B-cell lymphoma.
January 19th 2019
Robert Dean, MD, staff physician, Cleveland Clinic, discusses challenges in the mantle cell lymphoma (MCL) paradigm.
January 4th 2019
Robert Dean, MD, staff physician, Cleveland Clinic, discusses FDA approved drugs for patients with relapsed mantle cell lymphoma.
November 27th 2018
Robert Dean, MD, a staff physician at Cleveland Clinic, discusses ongoing research on biomarkers in mantle cell lymphoma (MCL).